Athersys Inc (ATHXQ)

[Seel]

RTI Biologics conf call reports positive MAP3 ramp up and opening of 'fairly large accounts'. Important for ATHX who will receive $ for licensing this tech and future royalties.

http://seekingalpha.com/article/2162163-rti-surgicals-ceo-discusses-q1-2014-results-earnings-call-transcript?page=4&p=qanda&l=last

RTI: Matt G. Hewitt – Craig-Hallum Capital Group LLC

All right. And then, I guess, shifting to map3. You’re making progress there. How does the inventory sit for that product? How should we think about that ramping over the course of this year?

Brian K. Hutchison

We are going to let both Carrie and Roger talk to that. Roger will start.

Roger W. Rose Jr

I think we’ve got plenty of inventory to hit the goals and objectives we got in place for the company for the year. As with any product launch, there is pacing that goes into that. And I think the ramp up that we’ve got right now underway is very appropriate. And I think our results are in line with our expectations.

Brian K. Hutchison

Carrie? You can talk to the floor.

Caroline A. Hartill

Yeah. I can discuss where we are in terms of serving the pipeline as it were with inventory. I describe this as being ahead of our expectations. We’ve certainly placed enough inventory on the shelf and available for our salespeople to become a much more confident in opening what are potentially fairly large new accounts. And so I think we’re very well positioned as we go into the second quarter.